Resistance analyses of integrase strand transfer inhibitors within phase 3 clinical trials of treatment-naive patients.
about
Multifunctional facets of retrovirus integraseMight dolutegravir be part of a functional cure for HIV?HIV-1 drug resistance and resistance testing.Reduced viral fitness and lack of cross-class resistance with integrase strand transfer inhibitor and nucleoside reverse transcriptase inhibitor resistance mutationsConcordance of HIV-1 RNA Values by Amplicor and TaqMan 2.0 in Patients With Confirmed Suppression in Clinical TrialsWill drug resistance against dolutegravir in initial therapy ever occur?Clinical pharmacokinetics and pharmacodynamics of dolutegravir used as a single tablet regimen for the treatment of HIV-1 infection.HIV-1 resistance to dolutegravir: update and new insights.Rare emergence of drug resistance in HIV-1 treatment-naïve patients after 48 weeks of treatment with elvitegravir/cobicistat/emtricitabine/tenofovir alafenamide.Antiretroviral resistance at virological failure in the NEAT 001/ANRS 143 trial: raltegravir plus darunavir/ritonavir or tenofovir/emtricitabine plus darunavir/ritonavir as first-line ART.
P2860
Q26795766-C1E75943-DC4D-4452-B2B4-5B90CA5C9072Q28071420-6F2FBE41-CBDF-41F8-8179-03B7F8A597E4Q30245693-300FA22B-690E-4DD0-A53C-F5F3DB27C277Q35607763-9A4D1593-EE5B-4B24-9543-E75335A8C014Q37221125-CFE51797-F4CB-4BD8-A6F6-3F6A70545140Q38478832-D5B3BAB3-6D56-4BC1-865F-C235E2D36734Q38541809-2FC80AA5-F703-47D8-A04E-BA40967155DDQ38915885-B97EDE5C-6BFD-4DB7-B5FF-0A29F3937AFFQ40785692-F1769C5B-C79C-4CD1-A185-1D9372DDFD5CQ40857943-28C363E3-797D-4E1F-A21B-673CAA5076FE
P2860
Resistance analyses of integrase strand transfer inhibitors within phase 3 clinical trials of treatment-naive patients.
description
2014 nî lūn-bûn
@nan
2014 թուականի Յուլիսին հրատարակուած գիտական յօդուած
@hyw
2014 թվականի հուլիսին հրատարակված գիտական հոդված
@hy
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
name
Resistance analyses of integra ...... s of treatment-naive patients.
@ast
Resistance analyses of integra ...... s of treatment-naive patients.
@en
type
label
Resistance analyses of integra ...... s of treatment-naive patients.
@ast
Resistance analyses of integra ...... s of treatment-naive patients.
@en
prefLabel
Resistance analyses of integra ...... s of treatment-naive patients.
@ast
Resistance analyses of integra ...... s of treatment-naive patients.
@en
P2093
P2860
P921
P356
P1433
P1476
Resistance analyses of integra ...... s of treatment-naive patients.
@en
P2093
Francois Raffi
Kirsten L White
Michael D Miller
P2860
P304
P356
10.3390/V6072858
P5008
P577
2014-07-22T00:00:00Z